Donald M. Berwick, MD, of the CMS provides specific advice and resources for implementing e-prescribing into your practice. Medscape Internal Medicine
No Comments »
Filed under: General Health News
Vaccines are projected to save the lives of more than 6 million children and spare an estimated $231 billion in treatment and related costs in the next decade, according an analysis of the “Decade of Vaccines” project. Medscape Medical News
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has issued a warning of an increased risk of high-grade prostate cancer with the 5-alpha reductase inhibitors finasteride (Proscar) and dutasteride (Avodart), currently approved to treat benign prostatic hypertrophy.
No Comments »
Filed under: General Health News
Interim efficacy and safety results from a long-term, 54-week, Phase III open-label study of Abbott’s investigational treatment for advanced Parkinson’s disease showed that patients treated with levodopa-carbidopa intestinal gel (LCIG) for 12 weeks reported a decrease in “off” time and an increase in “on” time without troublesome dyskinesias.
No Comments »
Filed under: Pharmacy News
Vertex Pharmaceuticals Incorporated and the Cystic Fibrosis Foundation today announced promising results from an ongoing Phase 2 study evaluating combinations of VX-770 and VX-809, potential medicines designed to treat the defective protein that causes cystic fibrosis.
No Comments »
Filed under: Pharmacy News
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company’s dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
No Comments »
Filed under: Pharmacy News
Vertex Pharmaceuticals Incorporated today announced interim results from the first part of a Phase 2 study designed to evaluate multiple combination regimens of VX-770 and VX-809, Vertex’s lead medicines in development that aim to treat the defective protein that causes cystic fibrosis.
No Comments »
Filed under: Pharmacy News
TGen Drug Development (TD2) and Imaging Endpoints have teamed up to enable the rapid development of anti-cancer drugs and deliver them faster to patients in need, the companies announced today.
No Comments »
Filed under: Pharmacy News
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that patient enrollment in the global pivotal Phase III clinical study CENTRIC has been completed.
No Comments »
Filed under: Pharmacy News
Neurologix, Inc. announced today several new results from the Company’s successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson’s disease (PD) as part of a comprehensive presentation of study findings to the National Institutes of Health (NIH) Recombinant DNA Advisory Committee.
No Comments »
Filed under: Pharmacy News
